CTRI Number |
CTRI/2019/03/018028 [Registered on: 12/03/2019] Trial Registered Prospectively |
Last Modified On: |
10/03/2019 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Benefit OF using two different type of drugs during operation. |
Scientific Title of Study
|
A Comparative study of clinical effects and recovery characteristics of intraoperative dexmedetomidine infusion with ketamine vs fentanyl as adjuvant |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Mehershree |
Designation |
junior resident |
Affiliation |
IMS,BHU,Varanasi |
Address |
Department Of Anaesthesiology,IMS,BHU,Varanasi
Department Of Anaesthesiology,IMS,BHU,Varanasi Varanasi UTTAR PRADESH 221005 India |
Phone |
9956867723 |
Fax |
|
Email |
meherlodhi7@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr A P Singh |
Designation |
Professor |
Affiliation |
IMS,BHU,Varanasi |
Address |
Department Of Anaesthesiology,IMS,BHU,Varanasi Department Of Anaesthesiology,IMS,BHU,Varanasi Varanasi UTTAR PRADESH 221005 India |
Phone |
9839412975 |
Fax |
|
Email |
bhuapsingh@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Mehershree |
Designation |
Junior resident |
Affiliation |
IMS,BHU,Varanasi |
Address |
Department Of Anaesthesiology,IMS,BHU,Varanasi Department Of Anaesthesiology,IMS,BHU,Varanasi Varanasi UTTAR PRADESH 221005 India |
Phone |
9839412975 |
Fax |
|
Email |
meherlodhi7@gmail.com |
|
Source of Monetary or Material Support
|
Institute of Medical Sciences,Banaras Hindu University,Varanasi-221005 |
|
Primary Sponsor
|
Name |
Institute of Medical Sciences |
Address |
Institute of Medical Sciences,Banaras Hindu University,Varanasi-221005 |
Type of Sponsor |
Government medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Mehershree |
IMS |
Department of Anaesthesiology, Institute of Medical Science,BHU Varanasi UTTAR PRADESH |
9956867723
meherlodhi7@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional ethical committee,Faculty of Medicine,Institute of Medical Sciences,Banaras Hindu University |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: C00-D49||Neoplasms, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Dexmedetomidine and ketamine infusion |
Intraoperatively Intravenous Dexmedetomidine 0.5μg/kg/hr in combination with ketamine 0.5mg/kg/hr infusion will be given . |
Comparator Agent |
Dexmedetomidine and Fentanyl infusion |
Intraoperatively Intravenous Dexmedetomidine 0.5μg/kg/hr in combination with Fentanyl 0.5μg/kg/hr infusion will be given |
|
Inclusion Criteria
|
Age From |
15.00 Year(s) |
Age To |
75.00 Year(s) |
Gender |
Both |
Details |
ASA GRADE I-II
Major Surgeries |
|
ExclusionCriteria |
Details |
1-Lack of patients consent
2-ASA Grade III-IV
3-Renal and Hepatic dysfunction
4-Respiratory disorder
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Recovery time,hemodynamic vital. |
10,20 min of induction,every 15 min throughout procedure |
|
Secondary Outcome
|
Outcome |
TimePoints |
Time for first analgesic requirements,duration of PACU stay |
2 hourly in postoperative period for 6 hours. |
|
Target Sample Size
|
Total Sample Size="80" Sample Size from India="80"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
20/03/2019 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="2" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
none |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
The study will be conducted in ,department of anaesthesiology,IMS ,BHU,VARANASI after written consent and institutional ethical approval.After CTRI registration ,80 patients of ASA grade I and II will be included.They will be randomly allocated to two groups of 40 patients each: DK (Dexmedetomidine & Ketamine) and DF (Dexmedetomidine & Fentanyl) groups. We will monitor extubation time ,recovery time,hemodynamic parameter (e.g.MAP,HR,SPO2 ,RR) and time for first analgesic requirements. |